Cargando…
Letter: Favorable Glycemic Control with Once-Daily Insulin Degludec/Insulin Aspart after Changing from Basal Insulin in Adults with Type 2 Diabetes (Endocrinol Metab 2019; 34:382-9, Han Na Jang et al.)
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Korean Endocrine Society
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7090304/ https://www.ncbi.nlm.nih.gov/pubmed/32207280 http://dx.doi.org/10.3803/EnM.2020.35.1.192 |
| _version_ | 1783509905097883648 |
|---|---|
| author | Rhee, Sang Youl |
| author_facet | Rhee, Sang Youl |
| author_sort | Rhee, Sang Youl |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7090304 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Korean Endocrine Society |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-70903042020-04-01 Letter: Favorable Glycemic Control with Once-Daily Insulin Degludec/Insulin Aspart after Changing from Basal Insulin in Adults with Type 2 Diabetes (Endocrinol Metab 2019; 34:382-9, Han Na Jang et al.) Rhee, Sang Youl Endocrinol Metab (Seoul) Letter Korean Endocrine Society 2020-03 2020-03-19 /pmc/articles/PMC7090304/ /pubmed/32207280 http://dx.doi.org/10.3803/EnM.2020.35.1.192 Text en Copyright © 2020 Korean Endocrine Society http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letter Rhee, Sang Youl Letter: Favorable Glycemic Control with Once-Daily Insulin Degludec/Insulin Aspart after Changing from Basal Insulin in Adults with Type 2 Diabetes (Endocrinol Metab 2019; 34:382-9, Han Na Jang et al.) |
| title | Letter: Favorable Glycemic Control with Once-Daily Insulin Degludec/Insulin Aspart after Changing from Basal Insulin in Adults with Type 2 Diabetes (Endocrinol Metab 2019; 34:382-9, Han Na Jang et al.) |
| title_full | Letter: Favorable Glycemic Control with Once-Daily Insulin Degludec/Insulin Aspart after Changing from Basal Insulin in Adults with Type 2 Diabetes (Endocrinol Metab 2019; 34:382-9, Han Na Jang et al.) |
| title_fullStr | Letter: Favorable Glycemic Control with Once-Daily Insulin Degludec/Insulin Aspart after Changing from Basal Insulin in Adults with Type 2 Diabetes (Endocrinol Metab 2019; 34:382-9, Han Na Jang et al.) |
| title_full_unstemmed | Letter: Favorable Glycemic Control with Once-Daily Insulin Degludec/Insulin Aspart after Changing from Basal Insulin in Adults with Type 2 Diabetes (Endocrinol Metab 2019; 34:382-9, Han Na Jang et al.) |
| title_short | Letter: Favorable Glycemic Control with Once-Daily Insulin Degludec/Insulin Aspart after Changing from Basal Insulin in Adults with Type 2 Diabetes (Endocrinol Metab 2019; 34:382-9, Han Na Jang et al.) |
| title_sort | letter: favorable glycemic control with once-daily insulin degludec/insulin aspart after changing from basal insulin in adults with type 2 diabetes (endocrinol metab 2019; 34:382-9, han na jang et al.) |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7090304/ https://www.ncbi.nlm.nih.gov/pubmed/32207280 http://dx.doi.org/10.3803/EnM.2020.35.1.192 |
| work_keys_str_mv | AT rheesangyoul letterfavorableglycemiccontrolwithoncedailyinsulindegludecinsulinaspartafterchangingfrombasalinsulininadultswithtype2diabetesendocrinolmetab2019343829hannajangetal |